Category Archives: Patent Eligibility (101)

DC section 101 ineligibility decision reversed since the “the claimed invention is also directed to a non-abstract improvement”

Koninkijke KPN N.V. v. Gemalto, et al. and LG Electronics, Inc. Docket Nos. 2018-1863-65 DYK, CHEN, STOLL November 15, 2019 Brief Summary: DC finding of invalidity under § 101 reversed (claims “employs a new way of generating check data”). Summary: … Continue reading

Posted in Patent Eligibility (101), Software, Uncategorized | Leave a comment

Method of treatment claims patent ineligible under 101 for being “focused on screening for a natural law” (“the invention does not improve treatment…by taking advantage of the body’s natural process”)

INO Therapeutics LLC, et al. v. Praxair Distribution Inc., et al. Docket No. 2018-1019 DYK, CHEN, STOLL August 27, 2019 Non-precedential Brief Summary: DC finding that “method of treating patients” claims ineligible under section 101 affirmed as the claims are … Continue reading

Posted in Claim Construction, Patent Eligibility (101), Patentability, Uncategorized | Leave a comment

DC decision that wireless communication claims are patent eligible under section 101 reversed

The Chamberlain Group, Inc. v. Techtronic Industries Co., et al. (“TTI”) Docket No. 2018-2103, -2228 LOURIE, O’MALLEY, CHEN August 21, 2019 Brief Summary: DC finding of no invalidity under section 101 reversed; anticipation finding affirmed. Summary: TTI appealed DC grant … Continue reading

Posted in Patent Eligibility (101), Patentability, Software, Uncategorized | Leave a comment

Federal Circuit denies Athena’s petition for rehearing of finding that its claims relating to a correlation between antibodies to a protein (“MuSK”) and neurological disorders are invalid under § 101.

Athena Diagnostics, Inc. et al. v. Mayo Collaborative Services, LLC Docket No. 2017-2508 NEWMAN (D), LOURIE, STOLL February 6, 2019 (Petition for rehearing denied July 3, 2019) Update (July 3, 2019): Athena’s petition for rehearing regarding the invalidation under § … Continue reading

Posted in Patent Eligibility (101), Patentability | Leave a comment

DC’s motion to dismiss and attorney fees award vacated and remanded as Cellspin’s amended complaint alleged an inventive concept and issued patents are presumed valid and patent eligible

Cellspin Soft, Inc. v. Fitbit, Inc. et al. (Moov, Nike, Fossil, Canon, GoPro, Panasonic, and JKI); Docket Nos. 2018-1817-26, -2178-84 (June 25, 2019) Brief Summary:  DC grant of Fitbit’s motion to dismiss for patent ineligibility under section 101 and the … Continue reading

Posted in Patent Eligibility (101), Patentability, Software | Leave a comment